Innovative Technology Altravax employs advanced Protein and Immunogen Optimization Systems, positioning it at the forefront of biopharmaceutical innovation with potential needs for specialized biotechnological tools and software solutions.
Growth Potential With annual revenue between 1 million and 10 million and recent funding of 2 million dollars, Altravax presents an opportunity for strategic partnerships to accelerate product development and market expansion.
Research Capabilities The company's Acclivity Biosystems division offers contract research services involving directed evolution and molecular biology, making it a prime candidate for partnerships around lab automation, data management, and specialized reagents.
Market Positioning Being a small, privately held biotech company in Sunnyvale, Altravax can benefit from collaborations with suppliers of laboratory equipment, cloud-based data solutions, and biotech-specific analytics to enhance research productivity.
Industry Ecosystem Altravax operates in a competitive landscape with rapidly evolving biotech firms, creating opportunities to offer innovative solutions in pharmaceutical research, regulatory compliance, and clinical trial support tailored to emerging biotech companies.
$500M$1B
$1M$10M
$100M$250M
$1B$10B
$100M$250M
$100M$250M
$50M$100M
$25M$50MAltravax, Inc. uses 8 technology products and services including WordPress, Google Cloud, jQuery, and more. Explore Altravax, Inc.'s tech stack below.
| Altravax, Inc. Email Formats | Percentage |
| First.Last@altravax.com | 50% |
| First.Last@altravax.com | 50% |
Biotechnology ResearchUnited States2-10 Employees
Altravax, Inc. is a privately held biopharmaceutical company with research laboratories and business operations in Sunnyvale, CA. Altravax uses its Protein and Immunogen Optimization Systems to create and improve protein function to prevent and treat disease. Altravax's Acclivity Biosystems division also offers contract research support for partner projects involving directed evolution and other molecular biology methodologies.
Company Overview
Funding & FinancialsAltravax, Inc. has raised a total of $2M of funding over 2 rounds. Their latest funding round was raised on Nov 30, 2009 in the amount of $2M.
Altravax, Inc.'s revenue is estimated to be in the range of $1M$10M
Funding & FinancialsAltravax, Inc. has raised a total of $2M of funding over 2 rounds. Their latest funding round was raised on Nov 30, 2009 in the amount of $2M.
Altravax, Inc.'s revenue is estimated to be in the range of $1M$10M
1-888-653-2347 
support@leadiq.com